4 Efforts to extend the life of native GLP-1 led to the development of human GLP-1 analogs liraglutide, albiglutide, dulaglutide, and semaglutide
Half-Life Extension Strategies Apart from DPP-4 enzymolysis, another GLP-1/GIP degradation pathway, renal metabolism, can be overcome by augmenting the drug volume to prolong the half-life
Moon et al suggested a hypothesis that GLP-1 Thr 13 interacts with a binding pocket formed by Ile 196 , Leu 232 , and Met 233 of GLP-1R because Thr 7 -containing chimeric peptides are highly sensitive for the Ile 196 mutation
During the early stages of its development, BPC 157 primarily garnered attention for its gastroprotective and ulcer-healing properties
Experimental investigations suggest that modulation of NNMT activity may influence cellular pathways associated with energy utilization, nutrient partitioning, and metabolic adaptation
Ipamorelin is not approved